GlucoTrack, Inc. Provides Development Update on its Gen 2 Non-Invasive Glucose Monitor
22 juin 2022 08h30 HE
|
GlucoTrack, Inc.
Rutherford, NJ and Or Yehuda, Israel, June 22, 2022 (GLOBE NEWSWIRE) -- GlucoTrack, Inc. (Nasdaq: GCTK) (“GlucoTrack” or the “Company”), a non-invasive device and digital health platform for...
GlucoTrack, Inc. Announces Effectiveness of Corporate Name Change and Ticker Symbol Change
14 mars 2022 09h15 HE
|
GlucoTrack, Inc.
To begin trading under the Nasdaq Symbol GCTK Rutherford, NJ and Or Yehuda, Israel, March 14, 2022 (GLOBE NEWSWIRE) -- GlucoTrack, Inc. (Nasdaq: GCTK) (“GlucoTrack” or the “Company”), formerly...